The importance being placed on digital media by pharma and med tech/device manufacturers has grown over the past few years as it has become apparent that relying on the...
Biological drugs, protein-based products derived from living cells using biotechnology, have been used since the 1990’s as a treatment option for cancer patients. Since 2009, biosimilar therapies (therapeutically equivalent subsequent entry biologics) have been available in different therapeutic areas in Canada, and are now on the verge of becoming available for use in oncology. MD Analytics asked 31 Canadian Oncologists and Hematologists for their views on the introduction of biosimilar therapies for cancer treatment.
Read More
The majority of Oncologists and Hematologists have some knowledge of biosimilars, but there is room to improve familiarity. 87% have biosimilar knowledge; 58% have basic knowledge; only 29% are very familiar. 3 in 4 specialists acknowledge biosimilars will aid patient access to optimal cancer treatments. However, only 1 in 10 strongly agree that they are looking forward to prescribing biosimilars.
Why is enthusiasm for biosimilars not stronger? Specialists have lingering concerns regarding: subpar patient support (84%); replicability (74%); payers mandating treatment changes (74%); disincentive to innovation (65%).
Past Survey Data
Pharma Leaders of Digital Media
While social media and digital tools have been playing an increasingly significant role in the personal lives of HCPs for many years now, use of these channels in a...
What could future physician practices look like with AI LLMs?
Artificial intelligence (AI) and large language models (LLMs), such as ChatGPT, are likely to be increasingly integrated into our healthcare systems which, in turn, may...
AI: How receptive have physicians been so far?
While artificial intelligence (AI) has been playing an increasingly significant role in various spheres of our lives for many years now, the topic of AI has jumped into...
Past Survey Data
What Digital Media do Physicians Use?
The importance being placed on digital media by pharma and med tech/device manufacturers has grown over the past few years as it has become apparent that relying on the...
Pharma Leaders of Digital Media
While social media and digital tools have been playing an increasingly significant role in the personal lives of HCPs for many years now, use of these channels in a...
What could future physician practices look like with AI LLMs?
Artificial intelligence (AI) and large language models (LLMs), such as ChatGPT, are likely to be increasingly integrated into our healthcare systems which, in turn, may...
AI: How receptive have physicians been so far?
While artificial intelligence (AI) has been playing an increasingly significant role in various spheres of our lives for many years now, the topic of AI has jumped into...